)
Bayer (BAYN) investor relations material
Bayer Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic positioning and market outlook
Positioned as a global leader in health and nutrition, with strong market shares in crop science, pharmaceuticals, and consumer health.
Expects above-market growth in crop science and significant opportunities in pharmaceuticals and consumer health.
Focused on innovation to address megatrends such as population growth, aging, and ecosystem pressures.
Mission centers on health for all and hunger for none, with divisional visions targeting disease treatment, self-care, and regenerative agriculture.
Financial performance and guidance
2025 net sales reached €45.6bn, with EBITDA before special items at €9.7bn and core EPS at €4.91.
Free cash flow declined to €2.1bn in 2025, impacted by higher incentive and litigation payouts.
Net financial debt reduced to €29.8bn in 2025, reflecting focused capital allocation and FX tailwinds.
2026 outlook reiterates guidance for stable sales and EBITDA, with improved net financial debt due to equity investment.
Innovation and R&D
Annual R&D investments of approximately €6bn support a robust pipeline across all divisions.
Crop science launched over 470 new seed products and 350 crop protection registrations in 2025.
Pharma pipeline includes launches such as EYLEA 8mg and NUBEQA, with leading technology platforms.
Consumer health maintains iconic brands and invests in start-ups through a strategic unit.
- Q2 2026 saw sales and earnings growth, positive net income, and reaffirmed guidance with lower debt.BAYN
Q2 20264 Aug 2026 - Sales up 3%, Crop Science led earnings, litigation hit cash flow, net debt outlook improved.BAYN
Q2 2026 (Media)4 Aug 2026 - Pharma and Consumer Health growth offset Crop Science decline; 2025 outlook steady amid legal, FX risks.BAYN
Q1 20259 Jul 2026 - New launches and pipeline advances drive growth despite Xarelto and Crop Science headwinds.BAYN
43rd Annual J.P. Morgan Healthcare Conference 20259 Jul 2026 - Aims for >€3.5bn sales growth, mid-20s EBITDA margin, and strong cash flow by 2029.BAYN
Investor Update9 Jul 2026 - Q2 sales rose 3.1% adjusted, but earnings fell on Crop Science and currency impacts.BAYN
Q2 2024 (Media)9 Jul 2026 - Impairments and FX headwinds drove earnings and margin declines despite stable sales.BAYN
Q3 20248 Jul 2026 - Shareholders approved all proposals as the company advanced its turnaround and innovation agenda.BAYN
AGM 20268 Jul 2026 - Core EPS surged and adjusted sales rose, but litigation and FX headwinds remain key challenges.BAYN
Q3 2025 (Media)8 Jul 2026
Next Bayer earnings date
Next Bayer earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)